Photo taken from Vivek Subbiah/Twitter
Sep 7, 2023, 19:58
Vivek Subbiah: Super delighted to Join Dr. Stephen V Liu to share my thoughts…
Quoting Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, on Twitter:
“Just in time for WCLC23 at The International Association for the Study of Lung Cancer for your post Labor Day motivation. Super delighted to Join Dr. Stephen V Liu to share my thoughts and vision for the future of clinical trials and dive into the world of
- Targeted therapies
- Phase1 trials
- Breaking down barriers to clinical trial enrollment
- New drugs
- Trial design and conduct
- Empowering fellows and new faculty and new oncologists to learn drug development and trial design to boost participation in clinical trials.”
For the podcast click here.
Source: Vivek Subbiah/Twitter